Bausch Health Cos Inventory 2010-2024 | BHC

Bausch Health Cos inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
Bausch Health Cos Annual Inventory
(Millions of US $)
2023 $1,544
2022 $1,090
2021 $993
2020 $1,094
2019 $1,107
2018 $934
2017 $1,048
2016 $1,061
2015 $1,257
2014 $889
2013 $883
2012 $531
2011 $355
2010 $230
2009 $83
Bausch Health Cos Quarterly Inventory
(Millions of US $)
2024-09-30 $1,655
2024-06-30 $1,612
2024-03-31 $1,636
2023-12-31 $1,544
2023-09-30 $1,272
2023-06-30 $1,240
2023-03-31 $1,222
2022-12-31 $1,090
2022-09-30 $1,056
2022-06-30 $1,073
2022-03-31 $1,045
2021-12-31 $993
2021-09-30 $1,058
2021-06-30 $1,086
2021-03-31 $1,076
2020-12-31 $1,094
2020-09-30 $1,224
2020-06-30 $1,226
2020-03-31 $1,124
2019-12-31 $1,107
2019-09-30 $1,100
2019-06-30 $1,060
2019-03-31 $1,012
2018-12-31 $934
2018-09-30 $971
2018-06-30 $993
2018-03-31 $1,042
2017-12-31 $1,048
2017-09-30 $1,071
2017-06-30 $1,084
2017-03-31 $1,111
2016-12-31 $1,061
2016-09-30 $1,300
2016-06-30 $1,337
2016-03-31 $1,320
2015-12-31 $1,257
2015-09-30 $1,199
2015-06-30 $1,230
2015-03-31 $999
2014-12-31 $889
2014-09-30 $933
2014-06-30 $943
2014-03-31 $953
2013-12-31 $883
2013-09-30 $1,076
2013-06-30 $497
2013-03-31 $510
2012-12-31 $531
2012-09-30 $418
2012-06-30 $389
2012-03-31 $374
2011-12-31 $355
2011-09-30 $260
2011-06-30 $260
2011-03-31 $266
2010-12-31 $230
2010-09-30 $295
2010-06-30 $88
2010-03-31 $98
2009-12-31 $83
2009-09-30 $74
2009-06-30 $70
2009-03-31 $60
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.009B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.350B 6.35
Dr Reddy's Laboratories (RDY) India $11.677B 22.35
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.142B 12.88
Supernus Pharmaceuticals (SUPN) United States $1.978B 26.93
Taysha Gene Therapies (TSHA) United States $0.447B 31.14
Personalis (PSNL) United States $0.239B 0.00
Assembly Biosciences (ASMB) United States $0.094B 0.00
Sol-Gel Technologies (SLGL) Israel $0.013B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00